Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo (Q45288791)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 May 2012

Language	Label	Description	Also known as
English	Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo	scientific article published on 24 May 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Huntington's disease

0 references

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

Christian T Sheline

1

object named as

Christian T Sheline

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Julia Zhu

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Wendy Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Chunxiao Shi

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Ai-Li Cai

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

24 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Neurodegenerative Diseases

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

49-58

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Energetics in the pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Recent advances in understanding the pathogenesis of Huntington's disease

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

The energetics of Huntington's disease

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid.

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

The mitochondrial toxin, 3-nitropropionic acid, induces extracellular Zn2+ accumulation in rat hippocampus slices

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment.

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Serum or target deprivation-induced neuronal death causes oxidative neuronal accumulation of Zn2+ and loss of NAD+.

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Neuronal death in cultured murine cortical cells is induced by inhibition of GAPDH and triosephosphate isomerase

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Free radical-mediated neurotoxicity may be caused by inhibition of mitochondrial dehydrogenases in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity.

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntingtons Disease - from Clinical Features to the Bench

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

3-Nitropropionic acid induces poly(ADP-ribosyl)ation and apoptosis related gene expression in the striatum in vivo

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Wld(S) mice are protected against the Parkinsonian mimetic MPTP.

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl 4-phenylpyridinium ion toxicity

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Mitochondrial disorders

1 reference

https://api.crossref.org/works/10.1159%2F000336558

21 January 2018

Identifiers

10.1159/000336558

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45288791&oldid=2073639366"